ACTEMRA Trademark

Trademark Overview

On Wednesday, March 19, 2003, a trademark application was filed for ACTEMRA with the United States Patent and Trademark Office. The USPTO has given the ACTEMRA trademark a serial number of 78227672. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, September 24, 2014. This trademark is owned by CHUGAI SEIYAKU KABUSHIKI KAISHA. The ACTEMRA trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PREPARATIONS, NAMELY, ANTI-INTERLEUKIN-6 (IL-6) RECEPTOR MONOCLONAL ANTIBODY FOR THE TREATMENT OF DISEASE CAUSED BY IL-6 PRODUCTION
actemra

General Information

Serial Number78227672
Word MarkACTEMRA
Filing DateWednesday, March 19, 2003
Status800 - REGISTERED AND RENEWED
Status DateWednesday, September 24, 2014
Registration Number2984926
Registration DateTuesday, August 16, 2005
Mark Drawing1 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 24, 2005

Trademark Statements

Goods and ServicesPHARMACEUTICAL PREPARATIONS, NAMELY, ANTI-INTERLEUKIN-6 (IL-6) RECEPTOR MONOCLONAL ANTIBODY FOR THE TREATMENT OF DISEASE CAUSED BY IL-6 PRODUCTION

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, April 5, 2003
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCHUGAI SEIYAKU KABUSHIKI KAISHA
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTOKYO
JP
Party NameCHUGAI SEIYAKU KABUSHIKI KAISHA
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTOKYO
JP
Party NameCHUGAI SEIYAKU KABUSHIKI KAISHA
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTOKYO
JP

Trademark Events

Event DateEvent Description
Friday, September 12, 2003NON-FINAL ACTION E-MAILED
Friday, September 12, 2003ASSIGNED TO EXAMINER
Friday, March 26, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 13, 2004NOTICE OF ALLOWANCE CANCELLED
Wednesday, December 24, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 29, 2003PAPER RECEIVED
Monday, December 29, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 11, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 31, 2004NOTICE OF PUBLICATION
Wednesday, March 31, 2004NOTICE OF PUBLICATION
Tuesday, April 20, 2004PUBLISHED FOR OPPOSITION
Tuesday, July 13, 2004NOA MAILED - SOU REQUIRED FROM APPLICANT
Thursday, April 14, 2005CASE RETURNED TO EXAMINATION
Tuesday, May 24, 2005PUBLISHED FOR OPPOSITION
Tuesday, August 16, 2005REGISTERED-PRINCIPAL REGISTER
Sunday, February 27, 2011CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, November 24, 2004PAPER RECEIVED
Wednesday, November 24, 2004PETITION TO DIRECTOR RECEIVED
Tuesday, March 22, 2005PETITION TO DIRECTOR GRANTED
Friday, April 15, 2005AMENDMENT/PETITION AFTER APPROVAL FOR PUB ENTERED
Wednesday, May 4, 2005NOTICE OF PUBLICATION
Thursday, February 10, 2011TEAS SECTION 8 & 15 RECEIVED
Wednesday, September 24, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, August 16, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, July 23, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Sunday, February 27, 2011REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, September 12, 2014TEAS SECTION 8 & 9 RECEIVED
Wednesday, September 24, 2014REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, September 24, 2014REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, September 24, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, June 5, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE

Related Keywords

actemra treatment antibody disease caused production monoclonal receptor preparations namely anti